-0.02 | -0.06%
| Price and Volume | |
|---|---|
| Recent Price | 32.56 |
| 52 Week High | 36.29 |
| 52 Week Low | 19.68 |
| Avg. Daily Vol. (Mil) | 0.10 |
| Beta (3 year) | 1.36 |
| Share Related Items | |
| Mkt Cap (Mil) | 706.23 |
| Shares Out (Mil) | 21.69 |
| Float (Mil) | 17.79 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 5.10 |
| Current Ratio | 6.90 |
| LT Debt/ Equity | 0.01 |
| Total Debt / Equity | 0.01 |
| Valuation Ratios | |
| Price Earnings | 56.10 |
| Price/Sales | 4.51 |
| Price/Book | 4.60 |
| Price/Cash Flow | 40.00 |
| Per Share Data | |
| Earnings | 0.58 |
| Sales | 7.22 |
| Book Value | 7.08 |
| Cash Flow | 0.81 |
| Business Summary | |
|---|---|
| Abaxis, Inc. develops, manufactures, markets and sells portable blood analysis systems for use in the human or veterinary patient-care setting to provide clinicians with rapid blood constituent measurements. | |
| General Information | |
| 3240 Whipple Road
Union, CA 94587 |
|
| www.abaxis.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 388 | |
| CEO: Mr. Clinton H. Severson | |
| Short Interest | |
| Current Month (Mil) | 1.26 |
| Previous Month (Mil) | 1.47 |
| Short Interest Ratio (Days) | 9.20 |
| Management Effectiveness | |
| Return on Equity | 7.70 |
| Return on Assets | 6.80 |
| Return on Investments | 7.60 |
| Profitability | |
| Gross Margin | 58.20 |
| EBIT Margin | 12.60 |
| Profit Margin | 8.40 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,454.83 | 1,317.82 | 2,837.53 | 17.45 |
Oil *
106.76
|
|
DOWN
74.92 |
DOWN
2.86 |
DOWN
1.85 |
DOWN
0.14 |
10 Yr
1.74%
SPDR Gold
152.68
|
|
-0.60%
|
-0.22%
|
-0.07%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet